Concepedia

Publication | Open Access

Suppression of Hepatic FLOT1 (Flotillin-1) by Type 2 Diabetes Mellitus Impairs the Disposal of Remnant Lipoproteins via Syndecan-1

DOIFull Paper Access

25

Citations

31

References

2017

Year

Keyang Chen, Qingsi Wu, Kong-wang Hu, Cheng‐Wei Yang, Xiangdong Wu, Peter Cheung, Kevin Jon Williams
Arteriosclerosis Thrombosis and Vascular Biology

Abstract

FLOT1 is a novel participant in the disposal of harmful C-TRLs via syndecan-1. Low expression of FLOT1 in T2DM liver may contribute to metabolic dyslipoproteinemia.

References

YearCitations

Page 1